🔎 Trials Near Me

Beranda › Kanker Paru › Georgia › Savannah

Uji klinis Kanker Paru di Savannah, GA

10 studi untuk Kanker Paru mencari peserta di lokasi sekitar Savannah (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Menerima pesertaFase 3
  • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
  • Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi jauhnya
  • South Carolina Cancer Specialists PC, Hilton Head Island · 22 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT04267848

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Low Country Cancer Care, Savannah
  • Memorial Health University Medical Center, Savannah
Usia 40 hingga 75 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05334069

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Menerima pesertaFase 3
  • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT04181060

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Menerima pesertaFase 3
  • Lewis Cancer and Research Pavilion ( Site 0063), Savannah
  • Saint Joseph's Candler Health System ( Site 4010), Bluffton · 18 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06312137

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Menerima pesertaFase 3
  • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
  • Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT05624996

Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)

Menerima pesertaFase 2
  • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
  • Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Jun 2026 · NCT05642572

Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)

Menerima pesertaFase 2/3
  • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
  • Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi jauhnya
  • South Carolina Cancer Specialists PC, Hilton Head Island · 22 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 5 Mei 2026 · NCT06616584

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

Menerima pesertaStudi observasional
  • Memorial Health University Medical Center, Savannah
  • Lewis Cancer and Research Pavilion at Saint Joseph's/Candler, Savannah
  • Saint Joseph's/Candler - Bluffton Campus, Bluffton · 18 mi jauhnya
  • dan 1 lainnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Jan 2026 · NCT06073431

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Menerima pesertaStudi observasional
  • Massive Bio SYNERGY-AI site, Savannah
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

Uji klinis Kanker Paru di kota lain

Studi lain di Savannah

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.